CORY BUNCH: Open Payments
NPI 1235213661 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 22 payments from 7 companies in 2025. Trend: 2023 $426 · 2024 $559 · 2025 $499
Food & beverage: $465Education: $34
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $202 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $43 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Amgen Inc. | 1 | $34 |
Products named: DUPIXENT, NEFFY, FASENRA, Rhapsido, TRELEGY ELLIPTA, XHANCE.
Industry payments across TN — which companies pay providers there.
